Product Images Duloxetine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Duloxetine Hydrochloride NDC 0615-8203 by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - duloxetine dr caps 30mg 60mg 1

structure - duloxetine dr caps 30mg 60mg 1

Torrent logo - duloxetine dr caps 30mg 60mg 10

Torrent logo - duloxetine dr caps 30mg 60mg 10

Duloxetine DR Caps 30mg bingo card label - duloxetine dr caps 30mg 60mg 11

Duloxetine DR Caps 30mg bingo card label - duloxetine dr caps 30mg 60mg 11

This is a pharmaceutical label for Duloxetine DR Caps USP 30 mg. Each capsule contains 33.68 mg of Duloxetine hydrochloride, USP equivalent to 30 mg of Duloxetine. The capsules should be dispensed in a tight container. Dosage information can be found in the package insert binder. It is for institutional use only and distributed by Torrent Ltd. The rest of the text appears to be a table with various lot numbers and quantities.*

Duloxetine DR Caps 60mg bingo card label - duloxetine dr caps 30mg 60mg 12

Duloxetine DR Caps 60mg bingo card label - duloxetine dr caps 30mg 60mg 12

This is a pharmaceutical package of Duloxetine DR Caps USP 60mg manufactured by Torrent Ltd. for Torrent Inc. The package has Lot number 8 8204 and the NDC 13668-111-30. The package also contains dosage and storage information. The text contains some errors and inconsistent dates.*

Figure 1 - duloxetine dr caps 30mg 60mg 2

Figure 1 - duloxetine dr caps 30mg 60mg 2

Figure 2 - duloxetine dr caps 30mg 60mg 3

Figure 2 - duloxetine dr caps 30mg 60mg 3

This is a graph that shows the proportion of patients with relapse on the y-axis and the time from randomization to relapse in days on the x-axis. There are two groups represented: placebo and Duoxatine, and the graph shows their respective proportions of relapse over time.*

Figure 3 - duloxetine dr caps 30mg 60mg 4

Figure 3 - duloxetine dr caps 30mg 60mg 4

Figure 4 - duloxetine dr caps 30mg 60mg 5

Figure 4 - duloxetine dr caps 30mg 60mg 5

Figure 7 - duloxetine dr caps 30mg 60mg 6

Figure 7 - duloxetine dr caps 30mg 60mg 6

Figure 8 - duloxetine dr caps 30mg 60mg 7

Figure 8 - duloxetine dr caps 30mg 60mg 7

The text appears to be a figure caption showing a graph depicting the percentage of patients achieving various levels of pain relief with placebo and Duloxetine 60 mg once daily. The graph shows the percent improvement in pain from baseline and has different values marked on the x-axis. No further description can be provided as there is no context available.*

Figure 9 - duloxetine dr caps 30mg 60mg 8

Figure 9 - duloxetine dr caps 30mg 60mg 8

logo - duloxetine dr caps 30mg 60mg 9

logo - duloxetine dr caps 30mg 60mg 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.